Physician profile
Julie Vu
NPI 1871729871
$1,290.61
in general payments reported to CMS, 2019-2025
9 companies · $51.14 in 2025
The $51.14 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,019 · 2020: $43.84 · 2023: $26.60 · 2024: $150 · 2025: $51.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $227.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,048.87 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $65.15 | 2024 | |
| Gynesonics, INC. | $46.11 | 2023-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Agile Therapeutics, INC. | $32.23 | 2024 | Twirla |
| Millicent US INC | $28.80 | 2024-2025 | Femlyv, Intrarosa |
| Astellas Pharma US INC | $19.96 | 2024 | Veozah |
| Optumhealth Care Solutions, LLC | $18.25 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Abbvie INC. | $17.21 | 2025 | |
| Duchesnay USA Incorporated | $14.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.